WebJul 6, 2024 · About Unum Therapeutics. Unum Therapeutics is a biopharmaceutical company focused on developing a pipeline of novel therapies to treat cancer patients. … WebApr 5, 2024 · If UNM closes above $40 at expiration, we would earn $1.55 per share on $38.45 per share at risk, or 4.03%. Over a 21-day holding period, the annualized return …
Seattle Genetics and Unum Therapeutics Enter into Strategic …
WebApr 13, 2024 · Life Edit Therapeutics, an ElevateBio portfolio company, is a gene editing company on a mission to rewrite the future by curing disease, making any edit, anywhere. Life Edit has built a world-class genome editing platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. WebFind the latest Unum Group (UNM) stock quote, history, news and other vital information to help you with your stock trading and investing. great debaters club london
Unum Group declares quarterly dividend of $0.33 per share of its …
WebMay 6, 2024 · Unum Therapeutics Inc. (UMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key … Web2 hours ago · CHATTANOOGA, Tenn., April 14, 2024 /PRNewswire/ -- Effective April 14, 2024, the Unum Group (NYSE:UNM) Board of Directors declared a quarterly dividend of $0.33 … WebUnum Therapeutics A New Therapy to Combat Multiple Cancers “Unum Therapeutics has been advancing rapidly. Two years ago, Unum had one bench in an incubator lab. Now, it … great debaters cast